Holdings over time
(Since January 1, 2022)
| Instrument | Avg. Exposure | Current Exposure | Time Holding | Last Closed |
|---|---|---|---|---|
 Sarepta (SRPT) | 4.01% | 2.49% | 100% | - |
 Vertex (VRTX) | 3.91% | 3.1% | 98.87% | - |
 Regeneron (REGN) | 3.85% | 3.09% | 100% | - |
 Amgen (AMGN) | 3.62% | 3.29% | 98.87% | - |
 Repligen (RGEN) | 3.57% | 3.46% | 100% | - |
 Alnylam (ALNY) | 3.55% | 3.55% | 98.87% | - |
 Bristol-Myers Squibb (BMY) | 3.53% | 4.1% | 98.87% | - |
 Jazz Pharmaceuticals (JAZZ) | 3.44% | 3.3% | 98.87% | - |
 Johnson & Johnson (JNJ) | 3.42% | 3.51% | 98.87% | - |
 Biogen (BIIB) | 3.35% | 2.68% | 100% | - |
 IQVIA (IQV) | 3.33% | 3.66% | 98.87% | - |
 CRISPR Therapeutics (CRSP) | 3.33% | 2.53% | 100% | - |
 Gilead Sciences (GILD) | 3.32% | 3.95% | 98.87% | - |
 Bio-Techne (TECH) | 3.32% | 3.31% | 100% | - |
 Pfizer (PFE) | 3.16% | 3.32% | 98.87% | - |
 Catalent (CTLT) | 3.14% | 0% | 89.66% | 6/26/2024 |
 Charles River Labs (CRL) | 3.05% | 3% | 98.87% | - |
 Intellia (NTLA) | 2.9% | 2.59% | 100% | - |
 Agilent (A) | 2.81% | 3.49% | 82.4% | - |
 Moderna (MRNA) | 2.78% | 1.49% | 98.87% | - |
 United Therapeutics (UTHR) | 2.57% | 0% | 70.93% | 1/4/2024 |
 GlaxoSmithKline (GSK) | 2.32% | 0% | 70.93% | 1/4/2024 |
 SpringWorks Therapeutics (SWTX) | 2.28% | 2.87% | 64.07% | - |
 Blueprint Medicines (BPMC) | 2.21% | 2.73% | 64.07% | - |
 AstraZeneca (AZN) | 2.18% | 3.16% | 64.07% | - |
 BeiGene (BGNE) | 2.16% | 5.4% | 64.07% | - |
 uniQure (QURE) | 1.94% | 4.11% | 65.2% | - |
 Sanofi (SNY) | 1.59% | 3.69% | 46.47% | - |
 Novartis (NVS) | 1.26% | 0% | 35.62% | 1/4/2024 |
 Ascendis Pharma (ASND) | 1.23% | 0% | 36.13% | 1/4/2024 |
 Bruker (BRKR) | 1.16% | 0% | 34.8% | 1/9/2023 |
 Revvity (RVTY) | 1.15% | 0% | 34.8% | 1/9/2023 |
 Vir (VIR) | 1.02% | 0% | 34.8% | 1/9/2023 |
 BioNTech SE (BNTX) | 0.94% | 0% | 34.8% | 1/9/2023 |
 Syneos Health Inc (SYNH) | 0.93% | 0% | 34.8% | 1/9/2023 |
 Alkermes (ALKS) | 0.92% | 3.88% | 27.94% | - |
 BioMarin (BMRN) | 0.86% | 2.63% | 27.94% | - |
 2Seventy Bio (TSVT) | 0.82% | 0% | 34.8% | 1/9/2023 |
 Fate Therapeutics (FATE) | 0.79% | 0% | 35.93% | 1/9/2023 |
 Allogene (ALLO) | 0.64% | 0% | 17.6% | 6/26/2024 |
 Caribou Biosciences (CRBU) | 0.54% | 0% | 17.6% | 6/26/2024 |
 Editas (EDIT) | 0.46% | 0% | 18.73% | 6/26/2024 |
 Catalyst Pharmaceuticals (CPRX) | 0.4% | 4.28% | 10.34% | - |
 Verve Therapeutics (VERV) | 0.37% | 3.17% | 10.34% | - |
 Exelixis (EXEL) | 0.37% | 3.87% | 10.34% | - |
 Pacific Biosciences (PACB) | 0.29% | 0% | 18.73% | 6/26/2024 |
 ProQR (PRQR) | 0.27% | 0% | 34.8% | 1/9/2023 |
 Bayer (BAYN.DE) | 0.07% | 0% | 1.13% | 1/11/2022 |
 Takeda (TAK) | 0.06% | 0% | 1.13% | 1/11/2022 |
 10X Genomics (TXG) | 0.06% | 0% | 1.13% | 1/11/2022 |
 Sangamo (SGMO) | 0.03% | 0% | 1.13% | 1/11/2022 |
 Invitae Corp (NVTAQ) | 0.02% | 0% | 1.13% | 1/11/2022 |
 Cellectis SA (CLLS) | 0.02% | 0% | 1.13% | 1/11/2022 |
 Adverum (ADVM) | 0.01% | 0% | 1.13% | 1/11/2022 |
Exposure over time
Exposure by Sector
Exposure by Country
Portfolio Time Machine
Portfolio date
01
01
2024
| Instrument | Invested | Value |
|---|---|---|
| Blueprint Medicines (BPMC) | 2.14% | 4.64% |
| Ascendis Pharma (ASND) | 3.61% | 4.57% |
| SpringWorks Therapeutics (SWTX) | 3.11% | 4.57% |
| Amgen (AMGN) | 3% | 4.1% |
| Repligen (RGEN) | 4.12% | 4.04% |
| Regeneron (REGN) | 2.63% | 3.89% |
| Vertex (VRTX) | 1.9% | 3.75% |
| Agilent (A) | 3.46% | 3.69% |
| Novartis (NVS) | 3.05% | 3.54% |
| Charles River Labs (CRL) | 4.35% | 3.53% |
| CRISPR Therapeutics (CRSP) | 3.33% | 3.52% |
| Gilead Sciences (GILD) | 2.75% | 3.37% |
| IQVIA (IQV) | 3.36% | 3.34% |
| GlaxoSmithKline (GSK) | 4.08% | 3.33% |
| Alnylam (ALNY) | 2.38% | 3.22% |
| AstraZeneca (AZN) | 3.11% | 3.22% |
| BeiGene (BGNE) | 3.78% | 3.18% |
| Jazz Pharmaceuticals (JAZZ) | 3.42% | 3.15% |
| Catalent (CTLT) | 5.17% | 3.13% |
| Bio-Techne (TECH) | 3.87% | 3.12% |
| United Therapeutics (UTHR) | 2.71% | 3.11% |
| Johnson & Johnson (JNJ) | 2.99% | 2.99% |
| Sanofi (SNY) | 2.65% | 2.95% |
| Biogen (BIIB) | 2.47% | 2.88% |
| Sarepta (SRPT) | 1.94% | 2.74% |
| Moderna (MRNA) | 4.61% | 2.6% |
| Bristol-Myers Squibb (BMY) | 2.95% | 2.52% |
| Pfizer (PFE) | 4.15% | 2.49% |
| Intellia (NTLA) | 4.04% | 2.37% |
| uniQure (QURE) | 4.31% | 1.81% |